PulseCheck” is a series within CardiaCast that is designed for Cardiovascular (CV) Team members who are new, or new to ...

In this week’s View, Dr. Eagle looks at the consequences of discontinuing long-term drug treatment in patients with heart ...

This page features ACC's full meeting coverage of the latest science from ACC.24 – including trial summaries, news stories, journal scans, videos and more.

In this week’s View, Dr. Eagle looks at the outcomes of balloon-expandable transcatheter aortic valve replacement (TAVR) in younger patients. He then explores the comparative effectiveness and safety ...

Join us in DC to bridge the gap between science and application!

This page features full coverage of the latest science from AHA 2017 – including trial summaries, news stories, journal scans, slides, videos and more. Check back during the meeting for additional ...

The U.S. Food and Drug Administration (FDA) has approved the FARAPULSE Pulsed Field Ablation System for isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic, ...

The following are key points to remember from a state-of-the-art review on treatment options for patients with secondary mitral regurgitation (SMR): ...

Cathleen Biga, MSN, FACC, is President and CEO of Cardiovascular Management of Illinois, a cardiology physician practice management company. She has worked with more than 100 cardiovascular providers ...

The American College of Cardiology is committed to improving diversity and inclusion within the cardiovascular workforce and the College's leadership and membership, and recognizes the success of its ...

Join Us When you become a member of the American College of Cardiology, you join a global community of cardiovascular professionals driven to transform cardiovascular care and improve heart health.

Tell us about you so we can serve you better. ACC requests information from its members on gender, ethnicity and race as part of the College's aim to develop a more diverse and inclusive ...